glp 1 agonist in pregnancy Glucagon-like peptide-1 receptor use pregnancy: a review glp 1 gestational diabetes Study

In a 48-week phase II clinical trial conducted on patients with type 2 diabetes and obesity, treatment with a dose of 10 mg/kg of bimagrumab resulted in a significant reduction in fat mass by 20.5% (compared to 0.5% in the placebo group), while lean body mass increased by 3.6% (as opposed to a decrease of 0.8% in the placebo group), leading to an overall body weight reduction of -6.5%, which was substantially better than the -0.8% observed in the placebo group

NAD+ Therapy: Recharges your cellular energy, clears mid-day brain fog, and supports long-term longevity

E.DrehmerE.PlateroJ

A few dietary supplements have shown to be effective in the prevention, treatment and recovery of Covid-19